PHM(Population Health Management) 보고서 : 구성요소, 제공 형태, 최종사용자, 지역별(2024-2032년)

The global population health management market size reached US$ 74.8 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 305.1 Billion by 2032, exhibiting a growth rate (CAGR) of 16.6% during 2024-2032.

Population health management (PHM) refers to a concentrated holistic approach of collecting and analyzing health-related data of a patient. It includes patient engagement, care coordination, integration, value-based care measurement, data analytics and health information management. It emphasizes on improving population health, improving the overall patient experience and easing healthcare outcomes. PHM also offers various solutions that assist in delivering patient-centric care by reducing readmission rates and ensuring appropriate and optimum interventions. It also aids in providing real-time access to medical information to both patients and healthcare providers. As a result, PHM is widely used by healthcare providers and government and private healthcare organizations.

Population Health Management Market Trends:

The rising geriatric population prone to chronic and acute medical ailments is one of the key factors driving the growth of the market. PHM is widely adopted to provide continuous surveillance and care to the patients due to the increasing prevalence of cardiological and neurological conditions. Additionally, the increasing utilization of PHM solutions to improve clinical outcomes for patients by providing access of medical information to healthcare professionals across diverse medical specialties is favoring the market growth. Moreover, various technological advancements, such as the integration of advanced analytics solutions that assist in faster and accurate diagnoses, digital delivery of data and generation of precise models for analyzing disease trajectory, are providing a thrust to the market growth. In line with this, the rising preference for personalized medicine is positively impacting the market growth. PHM solutions are used for providing individualized care based on the genetics, environment and behavior of the patient. Other factors, including significant growth in the healthcare industry, along with the implementation of various government initiatives for promoting public health, are anticipated to drive the market toward growth.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global population health management market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on component, mode of delivery and end user.

Breakup by Component:

Software

Services

Breakup by Mode of Delivery:

Cloud-based

Web-based

On-premises

Breakup by End User:

Healthcare Providers

Healthcare Payers

Employer Groups

Government Bodies

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Allscripts Healthcare Solutions Inc., Athenahealth Inc., Cerner Corporation, eClinicalWorks, Health Catalyst Inc., International Business Machines Corporation, Koninklijke Philips N.V., Lightbeam Health Solutions, McKesson Corporation, Nextgen Healthcare Inc., Optum Inc. (UnitedHealth Group Incorporated) and Symphony Performance Health Inc. (Press Ganey Associates).

Key Questions Answered in This Report

• 1. What was the size of the global population health management market in 2023?
• 2. What is the expected growth rate of the global population health management market during 2024-2032?
• 3. What are the key factors driving the global population health management market?
• 4. What has been the impact of COVID-19 on the global population health management market?
• 5. What is the breakup of the global population health management market based on the component?
• 6. What is the breakup of the global population health management market based on the mode of delivery?
• 7. What is the breakup of the global population health management market based on the end user?
• 8. What are the key regions in the global population health management market?
• 9. Who are the key players/companies in the global population health management market?

Table of Contents

1 Preface

2 Scope and Methodology

• 2.1 Objectives of the Study
• 2.2 Stakeholders
• 2.3 Data Sources
  • 2.3.1 Primary Sources
  • 2.3.2 Secondary Sources
• 2.4 Market Estimation
  • 2.4.1 Bottom-Up Approach
  • 2.4.2 Top-Down Approach
• 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

• 4.1 Overview
• 4.2 Key Industry Trends

5 Global Population Health Management Market

• 5.1 Market Overview
• 5.2 Market Performance
• 5.3 Impact of COVID-19
• 5.4 Market Forecast

6 Market Breakup by Component

• 6.1 Software
  • 6.1.1 Market Trends
  • 6.1.2 Market Forecast
• 6.2 Services
  • 6.2.1 Market Trends
  • 6.2.2 Market Forecast

7 Market Breakup by Mode of Delivery

• 7.1 Cloud-based
  • 7.1.1 Market Trends
  • 7.1.2 Market Forecast
• 7.2 Web-based
  • 7.2.1 Market Trends
  • 7.2.2 Market Forecast
• 7.3 On-premises
  • 7.3.1 Market Trends
  • 7.3.2 Market Forecast

8 Market Breakup by End User

• 8.1 Healthcare Providers
  • 8.1.1 Market Trends
  • 8.1.2 Market Forecast
• 8.2 Healthcare Payers
  • 8.2.1 Market Trends
  • 8.2.2 Market Forecast
• 8.3 Employer Groups
  • 8.3.1 Market Trends
  • 8.3.2 Market Forecast
• 8.4 Government Bodies
  • 8.4.1 Market Trends
  • 8.4.2 Market Forecast

9 Market Breakup by Region

• 9.1 North America
  • 9.1.1 United States
    • 9.1.1.1 Market Trends
    • 9.1.1.2 Market Forecast
  • 9.1.2 Canada
    • 9.1.2.1 Market Trends
    • 9.1.2.2 Market Forecast
• 9.2 Asia-Pacific
  • 9.2.1 China
    • 9.2.1.1 Market Trends
    • 9.2.1.2 Market Forecast
  • 9.2.2 Japan
    • 9.2.2.1 Market Trends
    • 9.2.2.2 Market Forecast
  • 9.2.3 India
    • 9.2.3.1 Market Trends
    • 9.2.3.2 Market Forecast
  • 9.2.4 South Korea
    • 9.2.4.1 Market Trends
    • 9.2.4.2 Market Forecast
  • 9.2.5 Australia
    • 9.2.5.1 Market Trends
    • 9.2.5.2 Market Forecast
  • 9.2.6 Indonesia
    • 9.2.6.1 Market Trends
    • 9.2.6.2 Market Forecast
  • 9.2.7 Others
    • 9.2.7.1 Market Trends
    • 9.2.7.2 Market Forecast
• 9.3 Europe
  • 9.3.1 Germany
    • 9.3.1.1 Market Trends
    • 9.3.1.2 Market Forecast
  • 9.3.2 France
    • 9.3.2.1 Market Trends
    • 9.3.2.2 Market Forecast
  • 9.3.3 United Kingdom
    • 9.3.3.1 Market Trends
    • 9.3.3.2 Market Forecast
  • 9.3.4 Italy
    • 9.3.4.1 Market Trends
    • 9.3.4.2 Market Forecast
  • 9.3.5 Spain
    • 9.3.5.1 Market Trends
    • 9.3.5.2 Market Forecast
  • 9.3.6 Russia
    • 9.3.6.1 Market Trends
    • 9.3.6.2 Market Forecast
  • 9.3.7 Others
    • 9.3.7.1 Market Trends
    • 9.3.7.2 Market Forecast
• 9.4 Latin America
  • 9.4.1 Brazil
    • 9.4.1.1 Market Trends
    • 9.4.1.2 Market Forecast
  • 9.4.2 Mexico
    • 9.4.2.1 Market Trends
    • 9.4.2.2 Market Forecast
  • 9.4.3 Others
    • 9.4.3.1 Market Trends
    • 9.4.3.2 Market Forecast
• 9.5 Middle East and Africa
  • 9.5.1 Market Trends
  • 9.5.2 Market Breakup by Country
  • 9.5.3 Market Forecast

10 SWOT Analysis

• 10.1 Overview
• 10.2 Strengths
• 10.3 Weaknesses
• 10.4 Opportunities
• 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

• 12.1 Overview
• 12.2 Bargaining Power of Buyers
• 12.3 Bargaining Power of Suppliers
• 12.4 Degree of Competition
• 12.5 Threat of New Entrants
• 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

• 14.1 Market Structure
• 14.2 Key Players
• 14.3 Profiles of Key Players
  • 14.3.1 Allscripts Healthcare Solutions Inc.
    • 14.3.1.1 Company Overview
    • 14.3.1.2 Product Portfolio
    • 14.3.1.3 Financials
    • 14.3.1.4 SWOT Analysis
  • 14.3.2 Athenahealth Inc.
    • 14.3.2.1 Company Overview
    • 14.3.2.2 Product Portfolio
  • 14.3.3 Cerner Corporation
    • 14.3.3.1 Company Overview
    • 14.3.3.2 Product Portfolio
    • 14.3.3.3 Financials
    • 14.3.3.4 SWOT Analysis
  • 14.3.4 eClinicalWorks
    • 14.3.4.1 Company Overview
    • 14.3.4.2 Product Portfolio
  • 14.3.5 Health Catalyst Inc.
    • 14.3.5.1 Company Overview
    • 14.3.5.2 Product Portfolio
    • 14.3.5.3 Financials
  • 14.3.6 International Business Machines Corporation
    • 14.3.6.1 Company Overview
    • 14.3.6.2 Product Portfolio
    • 14.3.6.3 Financials
    • 14.3.6.4 SWOT Analysis
  • 14.3.7 Koninklijke Philips N.V.
    • 14.3.7.1 Company Overview
    • 14.3.7.2 Product Portfolio
    • 14.3.7.3 Financials
    • 14.3.7.4 SWOT Analysis
  • 14.3.8 Lightbeam Health Solutions
    • 14.3.8.1 Company Overview
    • 14.3.8.2 Product Portfolio
  • 14.3.9 McKesson Corporation
    • 14.3.9.1 Company Overview
    • 14.3.9.2 Product Portfolio
    • 14.3.9.3 Financials
    • 14.3.9.4 SWOT Analysis
  • 14.3.10 Nextgen Healthcare Inc.
    • 14.3.10.1 Company Overview
    • 14.3.10.2 Product Portfolio
    • 14.3.10.3 Financials
    • 14.3.10.4 SWOT Analysis
  • 14.3.11 Optum Inc. (UnitedHealth Group Incorporated)
    • 14.3.11.1 Company Overview
    • 14.3.11.2 Product Portfolio
  • 14.3.12 Symphony Performance Health Inc. (Press Ganey Associates)
    • 14.3.12.1 Company Overview
    • 14.3.12.2 Product Portfolio